Action in Diabetes and Vascular disease - preterAx and diamicroN modified release Controlled Evaluation (2)
Action in Diabetes and Vascular disease - preterAx and diamicroN modified release Controlled Evaluation (3)
ADditional VAlue of NIR stents for treatment of long Coronary Lesions
ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy
Atherosclerotic Disease, Vascular function and genetic Epidemiology
CoreValve Advance International Post Market Study
Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)
ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction trial
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
Apixaban Dosed orally Vs. ANticoagulation with Enoxaparin-1
Apixaban Dosed orally Vs. ANticoagulation with Enoxaparin-2
Apixaban Dosed orally Vs. ANticoagulation with injectable Enoxaparin to prevent venous thromboembolism-3
Adalat CR and valsartan cost-effectiveness combination
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
Action in Diabetes and Vascular disease - preterAx and diamicroN modified release Controlled Evaluation-Observational study
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes
Assessment of Differences between Vioxx And Naproxen To Ascertain Gastrointestinal tolerability and Effectiveness study
An Exploratory Trial of Two Dosages of a Novel Synthetic Thrombin Inhibitor (Napsagatran, Ro 46-6240) Compared With Unfractionated Heparin for Treatment of Proximal Deep-Vein Thrombosis
Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke
Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals
Randomized Controlled Trial for Pulsed Field Ablation versus Standard of Care Ablation for Paroxysmal Atrial Fibrillation
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure
ADenosine Vasodilator Independent Stenosis Evaluation
ADenosine Vasodilator Independent Stenosis Evaluation II
Aortic Dissection Detection Risk Score Plus D-dimer in Suspected Acute Aortic Dissection
Avacopan Development in Vasculitis to Obtain Corticosteroid elimination and Therapeutic Efficacy
Advocates and Patients’ Advice to Enhance Breast Cancer Care Delivery, Patient Experience and Patient Centered Research by 2025
A Comprehensive Patient and Advocate-Led Study to Enhance Breast Cancer Care Delivery and Patient-Centered Research in Women Aged 80 Years
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis1
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis2
Acetazolamide in Decompensated Heart Failure with Volume OveRload
Comprehensive antenatal education birth preparation programmes to reduce the rates of caesarean section in nulliparous women
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Educational Impact on Apixaban Adherence in Atrial Fibrillation
The incidence of recurrent cardiovascular events among acute coronary syndrome patients treated with generic or original clopidogrel in relation to their sociodemographic and clinical characteristics
A cluster-randomized, placebo-controlled trial to evaluate the efficacy of a spatial repellent (Mosquito Shield™) against Aedes-borne virus infection among children ≥ 4-16 years of age in the Gampaha District, Sri Lanka
AlternativE Graft Investigational Study
AXERT Early Migraine Intervention Study
Airway Epithelial Gene Exprression in the Diagnosis of Lung Cancer-1
Airway Epithelial Gene Exprression in the Diagnosis of Lung Cancer-2
ApoA-I Event Reducing in Ischemic Syndromes I
ApoA-I Event Reducing in Ischemic Syndromes II
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Alendronate Elderly Osteoporosis Study
Association pour l'Etude et la Prévention de I'Endocardite Infectieuse
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer
Randomized Study to Assess the Efficacy of a Further 5 Years of Anastrozole Treatment for Postmenopausal Women with Breast Cancer Completing 5 Years Anastrozole Containing Adjuvant Endocrine Therapy
Randomized, double-blind, placebo-controlled, parallel-group Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD
Application of Economics & Social psychology to improve Opioid Prescribing Safety Trial-1
Application of Economics & Social psychology to improve Opioid Prescribing Safety trial-2
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression